VitalConnect reposted this
Medtech is moving fast this March, with major regulatory, financial, and strategic shifts reshaping the landscape. Tandem Diabetes Care and Visby Medical secured key FDA clearances, advancing chronic and infectious disease management. VitalConnect closed a $100M round to expand its footprint in cardiac monitoring. Shockwave Medical (Johnson & Johnson) launched a novel device for peripheral artery disease. Teleflex announced a corporate split following a 20% stock drop and acquired a major vascular intervention division from BIOTRONIK. On the M&A front, Medtronic, BD, and Boston Scientific are doubling down on high-growth areas from spine and diagnostics to renal denervation. Adaptability and strategic investment remain critical as the industry evolves. By Colin Miller. #medtech #medicaldevices #regulatoryaffairs #medicaltechnology
